nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—type 2 diabetes mellitus—hypertension	0.125	1	CtDrD
Valsartan—Angiotensin 2 Receptor Antagonists—Eprosartan—hypertension	0.0853	0.316	CiPCiCtD
Valsartan—Angiotensin 2 Receptor Antagonists—Telmisartan—hypertension	0.0646	0.24	CiPCiCtD
Valsartan—Angiotensin 2 Receptor Antagonists—Irbesartan—hypertension	0.0646	0.24	CiPCiCtD
Valsartan—Candesartan—hypertension	0.0598	0.292	CrCtD
Valsartan—AGTR1—hypertension	0.058	0.809	CbGaD
Valsartan—Irbesartan—hypertension	0.0556	0.271	CrCtD
Valsartan—Angiotensin 2 Receptor Antagonists—Losartan—hypertension	0.055	0.204	CiPCiCtD
Valsartan—Olmesartan—hypertension	0.0496	0.242	CrCtD
Valsartan—Losartan—hypertension	0.0402	0.196	CrCtD
Valsartan—AGTR1—Eprosartan—hypertension	0.0213	0.17	CbGbCtD
Valsartan—AGTR1—Candesartan—hypertension	0.0161	0.129	CbGbCtD
Valsartan—AGTR1—Olmesartan—hypertension	0.0144	0.115	CbGbCtD
Valsartan—ALB—hypertension	0.0137	0.191	CbGaD
Valsartan—Losartan—Eprosartan—hypertension	0.0135	0.0974	CrCrCtD
Valsartan—AGTR1—Telmisartan—hypertension	0.0115	0.092	CbGbCtD
Valsartan—AGTR1—Irbesartan—hypertension	0.00998	0.0797	CbGbCtD
Valsartan—Irbesartan—Candesartan—hypertension	0.00745	0.0537	CrCrCtD
Valsartan—Forasartan—Candesartan—hypertension	0.00745	0.0537	CrCrCtD
Valsartan—Forasartan—Irbesartan—hypertension	0.00692	0.0499	CrCrCtD
Valsartan—SLCO1B3—Olmesartan—hypertension	0.00663	0.053	CbGbCtD
Valsartan—Tasosartan—Candesartan—hypertension	0.00658	0.0474	CrCrCtD
Valsartan—AGTR1—Losartan—hypertension	0.00643	0.0514	CbGbCtD
Valsartan—Irbesartan—Olmesartan—hypertension	0.00617	0.0445	CrCrCtD
Valsartan—Forasartan—Olmesartan—hypertension	0.00617	0.0445	CrCrCtD
Valsartan—Tasosartan—Irbesartan—hypertension	0.00612	0.0441	CrCrCtD
Valsartan—Olmesartan—Telmisartan—hypertension	0.00592	0.0426	CrCrCtD
Valsartan—Olmesartan—Candesartan—hypertension	0.00592	0.0426	CrCrCtD
Valsartan—Olmesartan—Irbesartan—hypertension	0.0055	0.0396	CrCrCtD
Valsartan—Tasosartan—Olmesartan—hypertension	0.00545	0.0393	CrCrCtD
Valsartan—Losartan—Telmisartan—hypertension	0.00538	0.0388	CrCrCtD
Valsartan—Losartan—Candesartan—hypertension	0.00538	0.0388	CrCrCtD
Valsartan—SLCO1B3—Telmisartan—hypertension	0.0053	0.0424	CbGbCtD
Valsartan—Losartan—Irbesartan—hypertension	0.00501	0.0361	CrCrCtD
Valsartan—Irbesartan—Losartan—hypertension	0.00501	0.0361	CrCrCtD
Valsartan—Forasartan—Losartan—hypertension	0.00501	0.0361	CrCrCtD
Valsartan—Candesartan—Telmisartan—hypertension	0.00495	0.0357	CrCrCtD
Valsartan—Candesartan—Irbesartan—hypertension	0.0046	0.0332	CrCrCtD
Valsartan—Losartan—Olmesartan—hypertension	0.00446	0.0321	CrCrCtD
Valsartan—Tasosartan—Losartan—hypertension	0.00442	0.0319	CrCrCtD
Valsartan—Candesartan—Olmesartan—hypertension	0.0041	0.0295	CrCrCtD
Valsartan—Olmesartan—Losartan—hypertension	0.00398	0.0287	CrCrCtD
Valsartan—SLCO1B1—Olmesartan—hypertension	0.00386	0.0309	CbGbCtD
Valsartan—Candesartan—Losartan—hypertension	0.00333	0.024	CrCrCtD
Valsartan—SLCO1B3—Atorvastatin—hypertension	0.00324	0.0259	CbGbCtD
Valsartan—SLCO1B3—Losartan—hypertension	0.00296	0.0237	CbGbCtD
Valsartan—ALB—Ethacrynic acid—hypertension	0.00255	0.0204	CbGbCtD
Valsartan—SLCO1B1—Atorvastatin—hypertension	0.00189	0.0151	CbGbCtD
Valsartan—SLCO1B1—Losartan—hypertension	0.00172	0.0138	CbGbCtD
Valsartan—CYP2C9—Eprosartan—hypertension	0.00169	0.0135	CbGbCtD
Valsartan—SLCO1B1—Verapamil—hypertension	0.00152	0.0122	CbGbCtD
Valsartan—CYP2C9—Torasemide—hypertension	0.00137	0.011	CbGbCtD
Valsartan—CYP2C9—Candesartan—hypertension	0.00128	0.0102	CbGbCtD
Valsartan—CYP2C9—Guanfacine—hypertension	0.00128	0.0102	CbGbCtD
Valsartan—ALB—Captopril—hypertension	0.0012	0.00959	CbGbCtD
Valsartan—CYP2C9—Diltiazem—hypertension	0.000969	0.00774	CbGbCtD
Valsartan—ALB—Furosemide—hypertension	0.000964	0.0077	CbGbCtD
Valsartan—ALB—Losartan—hypertension	0.000944	0.00755	CbGbCtD
Valsartan—CYP2C9—Irbesartan—hypertension	0.00079	0.00631	CbGbCtD
Valsartan—CYP2C9—Amlodipine—hypertension	0.000774	0.00619	CbGbCtD
Valsartan—CYP2C9—Felodipine—hypertension	0.000747	0.00597	CbGbCtD
Valsartan—CYP2C9—Nifedipine—hypertension	0.000722	0.00577	CbGbCtD
Valsartan—CYP2C9—Nicardipine—hypertension	0.000711	0.00568	CbGbCtD
Valsartan—CYP2C9—Carvedilol—hypertension	0.000711	0.00568	CbGbCtD
Valsartan—AGTR1—nephron—hypertension	0.000677	0.146	CbGeAlD
Valsartan—CYP2C9—Atorvastatin—hypertension	0.000556	0.00445	CbGbCtD
Valsartan—CYP2C9—Losartan—hypertension	0.000509	0.00407	CbGbCtD
Valsartan—CYP2C9—Verapamil—hypertension	0.000449	0.00359	CbGbCtD
Valsartan—AGTR1—artery—hypertension	0.000378	0.0812	CbGeAlD
Valsartan—AGTR1—endothelium—hypertension	0.000319	0.0686	CbGeAlD
Valsartan—AGTR1—blood vessel—hypertension	0.000294	0.0632	CbGeAlD
Valsartan—CYP2C9—urine—hypertension	0.000262	0.0562	CbGeAlD
Valsartan—Tasosartan—AGTR2—hypertension	0.000256	0.279	CrCbGaD
Valsartan—AGTR1—cardiac ventricle—hypertension	0.000212	0.0455	CbGeAlD
Valsartan—AGTR1—myocardium—hypertension	0.000199	0.0428	CbGeAlD
Valsartan—SLCO1B3—endocrine gland—hypertension	0.000149	0.0319	CbGeAlD
Valsartan—AGTR1—nephron tubule—hypertension	0.000146	0.0314	CbGeAlD
Valsartan—Forasartan—AGTR1—hypertension	0.000146	0.16	CrCbGaD
Valsartan—AGTR1—adrenal cortex—hypertension	0.000144	0.0309	CbGeAlD
Valsartan—AGTR1—heart—hypertension	0.000139	0.0299	CbGeAlD
Valsartan—AGTR1—smooth muscle tissue—hypertension	0.000138	0.0297	CbGeAlD
Valsartan—AGTR1—decidua—hypertension	0.000135	0.0291	CbGeAlD
Valsartan—AGTR1—cardiovascular system—hypertension	0.000131	0.0282	CbGeAlD
Valsartan—AGTR1—kidney—hypertension	0.000129	0.0276	CbGeAlD
Valsartan—AGTR1—cortex of kidney—hypertension	0.000125	0.0269	CbGeAlD
Valsartan—SLCO1B1—kidney—hypertension	0.000123	0.0263	CbGeAlD
Valsartan—AGTR1—cardiac atrium—hypertension	0.000119	0.0256	CbGeAlD
Valsartan—AGTR1—medulla oblongata—hypertension	0.000112	0.0241	CbGeAlD
Valsartan—ALB—heart—hypertension	0.000107	0.0231	CbGeAlD
Valsartan—AGTR1—adrenal gland—hypertension	0.000104	0.0223	CbGeAlD
Valsartan—AGTR1—endocrine gland—hypertension	9.01e-05	0.0194	CbGeAlD
Valsartan—Tasosartan—AGTR1—hypertension	8.86e-05	0.0968	CrCbGaD
Valsartan—Irbesartan—EDNRA—hypertension	8.73e-05	0.0954	CrCbGaD
Valsartan—SLCO1B1—endocrine gland—hypertension	8.59e-05	0.0185	CbGeAlD
Valsartan—AGTR1—central nervous system—hypertension	8.12e-05	0.0174	CbGeAlD
Valsartan—ALB—adrenal gland—hypertension	8.02e-05	0.0172	CbGeAlD
Valsartan—Olmesartan—AGTR1—hypertension	7.49e-05	0.0818	CrCbGaD
Valsartan—CYP2C9—heart—hypertension	6.7e-05	0.0144	CbGeAlD
Valsartan—CYP2C9—cardiovascular system—hypertension	6.33e-05	0.0136	CbGeAlD
Valsartan—Candesartan—AGTR1—hypertension	5.82e-05	0.0636	CrCbGaD
Valsartan—Irbesartan—AGTR1—hypertension	5.82e-05	0.0636	CrCbGaD
Valsartan—CYP2C9—endocrine gland—hypertension	4.34e-05	0.00932	CbGeAlD
Valsartan—Losartan—AGTR1—hypertension	3.75e-05	0.041	CrCbGaD
Valsartan—Irbesartan—PTGS1—hypertension	2.71e-05	0.0296	CrCbGaD
Valsartan—Candesartan—PTGS1—hypertension	2.71e-05	0.0296	CrCbGaD
Valsartan—Losartan—CYP3A5—hypertension	2.35e-05	0.0257	CrCbGaD
Valsartan—Losartan—ACE—hypertension	2.17e-05	0.0237	CrCbGaD
Valsartan—Losartan—ALB—hypertension	8.88e-06	0.00971	CrCbGaD
Valsartan—Syncope—Lisinopril—hypertension	5.73e-06	0.000141	CcSEcCtD
Valsartan—Vomiting—Eplerenone—hypertension	5.73e-06	0.000141	CcSEcCtD
Valsartan—Rash—Fosinopril—hypertension	5.71e-06	0.000141	CcSEcCtD
Valsartan—Dermatitis—Fosinopril—hypertension	5.71e-06	0.000141	CcSEcCtD
Valsartan—Vomiting—Nifedipine—hypertension	5.69e-06	0.00014	CcSEcCtD
Valsartan—Gastrointestinal pain—Furosemide—hypertension	5.68e-06	0.00014	CcSEcCtD
Valsartan—Rash—Eplerenone—hypertension	5.68e-06	0.00014	CcSEcCtD
Valsartan—Urticaria—Perindopril—hypertension	5.68e-06	0.00014	CcSEcCtD
Valsartan—Headache—Fosinopril—hypertension	5.68e-06	0.00014	CcSEcCtD
Valsartan—Hypersensitivity—Trandolapril—hypertension	5.68e-06	0.00014	CcSEcCtD
Valsartan—Dermatitis—Eplerenone—hypertension	5.68e-06	0.00014	CcSEcCtD
Valsartan—Asthenia—Clonidine—hypertension	5.67e-06	0.00014	CcSEcCtD
Valsartan—Vomiting—Verapamil—hypertension	5.66e-06	0.00014	CcSEcCtD
Valsartan—Urticaria—Irbesartan—hypertension	5.66e-06	0.00014	CcSEcCtD
Valsartan—Shock—Ramipril—hypertension	5.66e-06	0.00014	CcSEcCtD
Valsartan—Hypersensitivity—Enalapril—hypertension	5.65e-06	0.00014	CcSEcCtD
Valsartan—Abdominal pain—Perindopril—hypertension	5.65e-06	0.000139	CcSEcCtD
Valsartan—Palpitations—Lisinopril—hypertension	5.65e-06	0.000139	CcSEcCtD
Valsartan—Diarrhoea—Olmesartan—hypertension	5.64e-06	0.000139	CcSEcCtD
Valsartan—Headache—Eplerenone—hypertension	5.64e-06	0.000139	CcSEcCtD
Valsartan—Rash—Nifedipine—hypertension	5.64e-06	0.000139	CcSEcCtD
Valsartan—Nervous system disorder—Ramipril—hypertension	5.64e-06	0.000139	CcSEcCtD
Valsartan—Dermatitis—Nifedipine—hypertension	5.63e-06	0.000139	CcSEcCtD
Valsartan—Abdominal pain—Irbesartan—hypertension	5.63e-06	0.000139	CcSEcCtD
Valsartan—Thrombocytopenia—Ramipril—hypertension	5.63e-06	0.000139	CcSEcCtD
Valsartan—Oedema—Timolol—hypertension	5.62e-06	0.000139	CcSEcCtD
Valsartan—Anaphylactic shock—Timolol—hypertension	5.62e-06	0.000139	CcSEcCtD
Valsartan—Loss of consciousness—Lisinopril—hypertension	5.61e-06	0.000139	CcSEcCtD
Valsartan—Rash—Verapamil—hypertension	5.61e-06	0.000139	CcSEcCtD
Valsartan—Urticaria—Hydrochlorothiazide—hypertension	5.61e-06	0.000139	CcSEcCtD
Valsartan—Dermatitis—Verapamil—hypertension	5.61e-06	0.000138	CcSEcCtD
Valsartan—Headache—Nifedipine—hypertension	5.6e-06	0.000138	CcSEcCtD
Valsartan—Pruritus—Clonidine—hypertension	5.59e-06	0.000138	CcSEcCtD
Valsartan—Abdominal pain—Hydrochlorothiazide—hypertension	5.59e-06	0.000138	CcSEcCtD
Valsartan—Skin disorder—Ramipril—hypertension	5.58e-06	0.000138	CcSEcCtD
Valsartan—Infection—Timolol—hypertension	5.58e-06	0.000138	CcSEcCtD
Valsartan—Headache—Verapamil—hypertension	5.58e-06	0.000138	CcSEcCtD
Valsartan—Hypersensitivity—Telmisartan—hypertension	5.58e-06	0.000138	CcSEcCtD
Valsartan—Cough—Lisinopril—hypertension	5.57e-06	0.000138	CcSEcCtD
Valsartan—Nausea—Indapamide—hypertension	5.56e-06	0.000137	CcSEcCtD
Valsartan—Nausea—Diltiazem—hypertension	5.56e-06	0.000137	CcSEcCtD
Valsartan—Asthenia—Trandolapril—hypertension	5.53e-06	0.000136	CcSEcCtD
Valsartan—Shock—Timolol—hypertension	5.53e-06	0.000136	CcSEcCtD
Valsartan—Urticaria—Furosemide—hypertension	5.52e-06	0.000136	CcSEcCtD
Valsartan—Nervous system disorder—Timolol—hypertension	5.51e-06	0.000136	CcSEcCtD
Valsartan—Nausea—Carvedilol—hypertension	5.51e-06	0.000136	CcSEcCtD
Valsartan—Asthenia—Enalapril—hypertension	5.51e-06	0.000136	CcSEcCtD
Valsartan—Abdominal pain—Furosemide—hypertension	5.49e-06	0.000136	CcSEcCtD
Valsartan—Gastrointestinal pain—Losartan—hypertension	5.48e-06	0.000135	CcSEcCtD
Valsartan—Anorexia—Ramipril—hypertension	5.48e-06	0.000135	CcSEcCtD
Valsartan—Urticaria—Betaxolol—hypertension	5.46e-06	0.000135	CcSEcCtD
Valsartan—Skin disorder—Timolol—hypertension	5.46e-06	0.000135	CcSEcCtD
Valsartan—Dizziness—Olmesartan—hypertension	5.46e-06	0.000135	CcSEcCtD
Valsartan—Pruritus—Trandolapril—hypertension	5.45e-06	0.000135	CcSEcCtD
Valsartan—Nausea—Doxazosin—hypertension	5.45e-06	0.000134	CcSEcCtD
Valsartan—Chest pain—Lisinopril—hypertension	5.44e-06	0.000134	CcSEcCtD
Valsartan—Myalgia—Lisinopril—hypertension	5.44e-06	0.000134	CcSEcCtD
Valsartan—Arthralgia—Lisinopril—hypertension	5.44e-06	0.000134	CcSEcCtD
Valsartan—Asthenia—Telmisartan—hypertension	5.43e-06	0.000134	CcSEcCtD
Valsartan—Pruritus—Enalapril—hypertension	5.43e-06	0.000134	CcSEcCtD
Valsartan—Anxiety—Lisinopril—hypertension	5.42e-06	0.000134	CcSEcCtD
Valsartan—Diarrhoea—Clonidine—hypertension	5.41e-06	0.000133	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	5.4e-06	0.000133	CcSEcCtD
Valsartan—Nausea—Fosinopril—hypertension	5.38e-06	0.000133	CcSEcCtD
Valsartan—Hypotension—Ramipril—hypertension	5.37e-06	0.000133	CcSEcCtD
Valsartan—Anorexia—Timolol—hypertension	5.36e-06	0.000132	CcSEcCtD
Valsartan—Pruritus—Telmisartan—hypertension	5.36e-06	0.000132	CcSEcCtD
Valsartan—Nausea—Eplerenone—hypertension	5.35e-06	0.000132	CcSEcCtD
Valsartan—Urticaria—Losartan—hypertension	5.33e-06	0.000131	CcSEcCtD
Valsartan—Dry mouth—Lisinopril—hypertension	5.32e-06	0.000131	CcSEcCtD
Valsartan—Nausea—Nifedipine—hypertension	5.31e-06	0.000131	CcSEcCtD
Valsartan—Abdominal pain—Losartan—hypertension	5.3e-06	0.000131	CcSEcCtD
Valsartan—Nausea—Verapamil—hypertension	5.29e-06	0.000131	CcSEcCtD
Valsartan—Asthenia—Captopril—hypertension	5.28e-06	0.00013	CcSEcCtD
Valsartan—Diarrhoea—Trandolapril—hypertension	5.27e-06	0.00013	CcSEcCtD
Valsartan—Diarrhoea—Enalapril—hypertension	5.25e-06	0.00013	CcSEcCtD
Valsartan—Hypotension—Timolol—hypertension	5.25e-06	0.00013	CcSEcCtD
Valsartan—Hypersensitivity—Irbesartan—hypertension	5.25e-06	0.00013	CcSEcCtD
Valsartan—Vomiting—Olmesartan—hypertension	5.25e-06	0.000129	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Ramipril—hypertension	5.24e-06	0.000129	CcSEcCtD
Valsartan—Dizziness—Clonidine—hypertension	5.23e-06	0.000129	CcSEcCtD
Valsartan—Anaphylactic shock—Lisinopril—hypertension	5.21e-06	0.000129	CcSEcCtD
Valsartan—Oedema—Lisinopril—hypertension	5.21e-06	0.000129	CcSEcCtD
Valsartan—Pruritus—Captopril—hypertension	5.21e-06	0.000129	CcSEcCtD
Valsartan—Hypersensitivity—Hydrochlorothiazide—hypertension	5.21e-06	0.000128	CcSEcCtD
Valsartan—Rash—Olmesartan—hypertension	5.2e-06	0.000128	CcSEcCtD
Valsartan—Insomnia—Ramipril—hypertension	5.2e-06	0.000128	CcSEcCtD
Valsartan—Dermatitis—Olmesartan—hypertension	5.2e-06	0.000128	CcSEcCtD
Valsartan—Diarrhoea—Telmisartan—hypertension	5.18e-06	0.000128	CcSEcCtD
Valsartan—Infection—Lisinopril—hypertension	5.18e-06	0.000128	CcSEcCtD
Valsartan—Headache—Olmesartan—hypertension	5.17e-06	0.000128	CcSEcCtD
Valsartan—Paraesthesia—Ramipril—hypertension	5.16e-06	0.000127	CcSEcCtD
Valsartan—Shock—Lisinopril—hypertension	5.13e-06	0.000127	CcSEcCtD
Valsartan—Asthenia—Perindopril—hypertension	5.13e-06	0.000127	CcSEcCtD
Valsartan—Dyspnoea—Ramipril—hypertension	5.13e-06	0.000126	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Timolol—hypertension	5.12e-06	0.000126	CcSEcCtD
Valsartan—Hypersensitivity—Furosemide—hypertension	5.12e-06	0.000126	CcSEcCtD
Valsartan—Asthenia—Irbesartan—hypertension	5.11e-06	0.000126	CcSEcCtD
Valsartan—Somnolence—Ramipril—hypertension	5.11e-06	0.000126	CcSEcCtD
Valsartan—Thrombocytopenia—Lisinopril—hypertension	5.1e-06	0.000126	CcSEcCtD
Valsartan—Dizziness—Trandolapril—hypertension	5.1e-06	0.000126	CcSEcCtD
Valsartan—Insomnia—Timolol—hypertension	5.08e-06	0.000125	CcSEcCtD
Valsartan—Dizziness—Enalapril—hypertension	5.08e-06	0.000125	CcSEcCtD
Valsartan—Asthenia—Hydrochlorothiazide—hypertension	5.07e-06	0.000125	CcSEcCtD
Valsartan—Hypersensitivity—Betaxolol—hypertension	5.07e-06	0.000125	CcSEcCtD
Valsartan—Skin disorder—Lisinopril—hypertension	5.06e-06	0.000125	CcSEcCtD
Valsartan—Dyspepsia—Ramipril—hypertension	5.06e-06	0.000125	CcSEcCtD
Valsartan—Pruritus—Perindopril—hypertension	5.06e-06	0.000125	CcSEcCtD
Valsartan—Paraesthesia—Timolol—hypertension	5.05e-06	0.000125	CcSEcCtD
Valsartan—Pruritus—Irbesartan—hypertension	5.04e-06	0.000124	CcSEcCtD
Valsartan—Diarrhoea—Captopril—hypertension	5.04e-06	0.000124	CcSEcCtD
Valsartan—Vomiting—Clonidine—hypertension	5.02e-06	0.000124	CcSEcCtD
Valsartan—Dyspnoea—Timolol—hypertension	5.01e-06	0.000124	CcSEcCtD
Valsartan—Dizziness—Telmisartan—hypertension	5.01e-06	0.000124	CcSEcCtD
Valsartan—Pruritus—Hydrochlorothiazide—hypertension	5e-06	0.000123	CcSEcCtD
Valsartan—Decreased appetite—Ramipril—hypertension	5e-06	0.000123	CcSEcCtD
Valsartan—Somnolence—Timolol—hypertension	5e-06	0.000123	CcSEcCtD
Valsartan—Asthenia—Furosemide—hypertension	4.99e-06	0.000123	CcSEcCtD
Valsartan—Rash—Clonidine—hypertension	4.98e-06	0.000123	CcSEcCtD
Valsartan—Dermatitis—Clonidine—hypertension	4.98e-06	0.000123	CcSEcCtD
Valsartan—Anorexia—Lisinopril—hypertension	4.97e-06	0.000123	CcSEcCtD
Valsartan—Gastrointestinal disorder—Ramipril—hypertension	4.96e-06	0.000122	CcSEcCtD
Valsartan—Fatigue—Ramipril—hypertension	4.96e-06	0.000122	CcSEcCtD
Valsartan—Headache—Clonidine—hypertension	4.95e-06	0.000122	CcSEcCtD
Valsartan—Dyspepsia—Timolol—hypertension	4.95e-06	0.000122	CcSEcCtD
Valsartan—Hypersensitivity—Losartan—hypertension	4.94e-06	0.000122	CcSEcCtD
Valsartan—Asthenia—Betaxolol—hypertension	4.94e-06	0.000122	CcSEcCtD
Valsartan—Pruritus—Furosemide—hypertension	4.92e-06	0.000121	CcSEcCtD
Valsartan—Constipation—Ramipril—hypertension	4.92e-06	0.000121	CcSEcCtD
Valsartan—Nausea—Olmesartan—hypertension	4.9e-06	0.000121	CcSEcCtD
Valsartan—Vomiting—Trandolapril—hypertension	4.9e-06	0.000121	CcSEcCtD
Valsartan—Diarrhoea—Perindopril—hypertension	4.89e-06	0.000121	CcSEcCtD
Valsartan—Decreased appetite—Timolol—hypertension	4.89e-06	0.000121	CcSEcCtD
Valsartan—Vomiting—Enalapril—hypertension	4.88e-06	0.00012	CcSEcCtD
Valsartan—Diarrhoea—Irbesartan—hypertension	4.87e-06	0.00012	CcSEcCtD
Valsartan—Hypotension—Lisinopril—hypertension	4.87e-06	0.00012	CcSEcCtD
Valsartan—Dizziness—Captopril—hypertension	4.87e-06	0.00012	CcSEcCtD
Valsartan—Pruritus—Betaxolol—hypertension	4.87e-06	0.00012	CcSEcCtD
Valsartan—Rash—Trandolapril—hypertension	4.86e-06	0.00012	CcSEcCtD
Valsartan—Dermatitis—Trandolapril—hypertension	4.85e-06	0.00012	CcSEcCtD
Valsartan—Gastrointestinal disorder—Timolol—hypertension	4.85e-06	0.00012	CcSEcCtD
Valsartan—Fatigue—Timolol—hypertension	4.85e-06	0.00012	CcSEcCtD
Valsartan—Rash—Enalapril—hypertension	4.84e-06	0.000119	CcSEcCtD
Valsartan—Dermatitis—Enalapril—hypertension	4.84e-06	0.000119	CcSEcCtD
Valsartan—Diarrhoea—Hydrochlorothiazide—hypertension	4.83e-06	0.000119	CcSEcCtD
Valsartan—Headache—Trandolapril—hypertension	4.83e-06	0.000119	CcSEcCtD
Valsartan—Vomiting—Telmisartan—hypertension	4.81e-06	0.000119	CcSEcCtD
Valsartan—Asthenia—Losartan—hypertension	4.81e-06	0.000119	CcSEcCtD
Valsartan—Headache—Enalapril—hypertension	4.81e-06	0.000119	CcSEcCtD
Valsartan—Rash—Telmisartan—hypertension	4.77e-06	0.000118	CcSEcCtD
Valsartan—Dermatitis—Telmisartan—hypertension	4.77e-06	0.000118	CcSEcCtD
Valsartan—Diarrhoea—Furosemide—hypertension	4.75e-06	0.000117	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Lisinopril—hypertension	4.75e-06	0.000117	CcSEcCtD
Valsartan—Pruritus—Losartan—hypertension	4.74e-06	0.000117	CcSEcCtD
Valsartan—Headache—Telmisartan—hypertension	4.74e-06	0.000117	CcSEcCtD
Valsartan—Dizziness—Perindopril—hypertension	4.73e-06	0.000117	CcSEcCtD
Valsartan—Insomnia—Lisinopril—hypertension	4.72e-06	0.000116	CcSEcCtD
Valsartan—Dizziness—Irbesartan—hypertension	4.71e-06	0.000116	CcSEcCtD
Valsartan—Diarrhoea—Betaxolol—hypertension	4.71e-06	0.000116	CcSEcCtD
Valsartan—Gastrointestinal pain—Ramipril—hypertension	4.7e-06	0.000116	CcSEcCtD
Valsartan—Nausea—Clonidine—hypertension	4.69e-06	0.000116	CcSEcCtD
Valsartan—Paraesthesia—Lisinopril—hypertension	4.68e-06	0.000116	CcSEcCtD
Valsartan—Vomiting—Captopril—hypertension	4.68e-06	0.000116	CcSEcCtD
Valsartan—Dizziness—Hydrochlorothiazide—hypertension	4.67e-06	0.000115	CcSEcCtD
Valsartan—Dyspnoea—Lisinopril—hypertension	4.65e-06	0.000115	CcSEcCtD
Valsartan—Rash—Captopril—hypertension	4.64e-06	0.000115	CcSEcCtD
Valsartan—Dermatitis—Captopril—hypertension	4.64e-06	0.000114	CcSEcCtD
Valsartan—Somnolence—Lisinopril—hypertension	4.63e-06	0.000114	CcSEcCtD
Valsartan—Headache—Captopril—hypertension	4.61e-06	0.000114	CcSEcCtD
Valsartan—Gastrointestinal pain—Timolol—hypertension	4.6e-06	0.000113	CcSEcCtD
Valsartan—Dizziness—Furosemide—hypertension	4.59e-06	0.000113	CcSEcCtD
Valsartan—Dyspepsia—Lisinopril—hypertension	4.59e-06	0.000113	CcSEcCtD
Valsartan—Diarrhoea—Losartan—hypertension	4.59e-06	0.000113	CcSEcCtD
Valsartan—Nausea—Trandolapril—hypertension	4.58e-06	0.000113	CcSEcCtD
Valsartan—Urticaria—Ramipril—hypertension	4.57e-06	0.000113	CcSEcCtD
Valsartan—Nausea—Enalapril—hypertension	4.56e-06	0.000113	CcSEcCtD
Valsartan—Dizziness—Betaxolol—hypertension	4.55e-06	0.000112	CcSEcCtD
Valsartan—Vomiting—Perindopril—hypertension	4.54e-06	0.000112	CcSEcCtD
Valsartan—Abdominal pain—Ramipril—hypertension	4.54e-06	0.000112	CcSEcCtD
Valsartan—Decreased appetite—Lisinopril—hypertension	4.53e-06	0.000112	CcSEcCtD
Valsartan—Vomiting—Irbesartan—hypertension	4.53e-06	0.000112	CcSEcCtD
Valsartan—Rash—Perindopril—hypertension	4.51e-06	0.000111	CcSEcCtD
Valsartan—Dermatitis—Perindopril—hypertension	4.5e-06	0.000111	CcSEcCtD
Valsartan—Gastrointestinal disorder—Lisinopril—hypertension	4.5e-06	0.000111	CcSEcCtD
Valsartan—Nausea—Telmisartan—hypertension	4.5e-06	0.000111	CcSEcCtD
Valsartan—Fatigue—Lisinopril—hypertension	4.49e-06	0.000111	CcSEcCtD
Valsartan—Vomiting—Hydrochlorothiazide—hypertension	4.49e-06	0.000111	CcSEcCtD
Valsartan—Rash—Irbesartan—hypertension	4.49e-06	0.000111	CcSEcCtD
Valsartan—Dermatitis—Irbesartan—hypertension	4.49e-06	0.000111	CcSEcCtD
Valsartan—Headache—Perindopril—hypertension	4.48e-06	0.00011	CcSEcCtD
Valsartan—Urticaria—Timolol—hypertension	4.46e-06	0.00011	CcSEcCtD
Valsartan—Headache—Irbesartan—hypertension	4.46e-06	0.00011	CcSEcCtD
Valsartan—Constipation—Lisinopril—hypertension	4.46e-06	0.00011	CcSEcCtD
Valsartan—Rash—Hydrochlorothiazide—hypertension	4.45e-06	0.00011	CcSEcCtD
Valsartan—Dermatitis—Hydrochlorothiazide—hypertension	4.45e-06	0.00011	CcSEcCtD
Valsartan—Abdominal pain—Timolol—hypertension	4.44e-06	0.00011	CcSEcCtD
Valsartan—Dizziness—Losartan—hypertension	4.43e-06	0.000109	CcSEcCtD
Valsartan—Headache—Hydrochlorothiazide—hypertension	4.43e-06	0.000109	CcSEcCtD
Valsartan—Vomiting—Furosemide—hypertension	4.42e-06	0.000109	CcSEcCtD
Valsartan—Rash—Furosemide—hypertension	4.38e-06	0.000108	CcSEcCtD
Valsartan—Dermatitis—Furosemide—hypertension	4.38e-06	0.000108	CcSEcCtD
Valsartan—Vomiting—Betaxolol—hypertension	4.37e-06	0.000108	CcSEcCtD
Valsartan—Nausea—Captopril—hypertension	4.37e-06	0.000108	CcSEcCtD
Valsartan—Headache—Furosemide—hypertension	4.35e-06	0.000107	CcSEcCtD
Valsartan—Rash—Betaxolol—hypertension	4.34e-06	0.000107	CcSEcCtD
Valsartan—Dermatitis—Betaxolol—hypertension	4.33e-06	0.000107	CcSEcCtD
Valsartan—Headache—Betaxolol—hypertension	4.31e-06	0.000106	CcSEcCtD
Valsartan—Gastrointestinal pain—Lisinopril—hypertension	4.26e-06	0.000105	CcSEcCtD
Valsartan—Vomiting—Losartan—hypertension	4.26e-06	0.000105	CcSEcCtD
Valsartan—Nausea—Perindopril—hypertension	4.25e-06	0.000105	CcSEcCtD
Valsartan—Hypersensitivity—Ramipril—hypertension	4.24e-06	0.000105	CcSEcCtD
Valsartan—Nausea—Irbesartan—hypertension	4.23e-06	0.000104	CcSEcCtD
Valsartan—Rash—Losartan—hypertension	4.23e-06	0.000104	CcSEcCtD
Valsartan—Dermatitis—Losartan—hypertension	4.22e-06	0.000104	CcSEcCtD
Valsartan—Headache—Losartan—hypertension	4.2e-06	0.000104	CcSEcCtD
Valsartan—Nausea—Hydrochlorothiazide—hypertension	4.2e-06	0.000104	CcSEcCtD
Valsartan—Urticaria—Lisinopril—hypertension	4.14e-06	0.000102	CcSEcCtD
Valsartan—Hypersensitivity—Timolol—hypertension	4.14e-06	0.000102	CcSEcCtD
Valsartan—Nausea—Furosemide—hypertension	4.13e-06	0.000102	CcSEcCtD
Valsartan—Asthenia—Ramipril—hypertension	4.12e-06	0.000102	CcSEcCtD
Valsartan—Abdominal pain—Lisinopril—hypertension	4.12e-06	0.000102	CcSEcCtD
Valsartan—Nausea—Betaxolol—hypertension	4.09e-06	0.000101	CcSEcCtD
Valsartan—Pruritus—Ramipril—hypertension	4.07e-06	0.0001	CcSEcCtD
Valsartan—Asthenia—Timolol—hypertension	4.03e-06	9.95e-05	CcSEcCtD
Valsartan—Nausea—Losartan—hypertension	3.98e-06	9.83e-05	CcSEcCtD
Valsartan—Pruritus—Timolol—hypertension	3.98e-06	9.81e-05	CcSEcCtD
Valsartan—Diarrhoea—Ramipril—hypertension	3.93e-06	9.71e-05	CcSEcCtD
Valsartan—Diarrhoea—Timolol—hypertension	3.85e-06	9.49e-05	CcSEcCtD
Valsartan—Hypersensitivity—Lisinopril—hypertension	3.84e-06	9.48e-05	CcSEcCtD
Valsartan—Dizziness—Ramipril—hypertension	3.8e-06	9.38e-05	CcSEcCtD
Valsartan—Asthenia—Lisinopril—hypertension	3.74e-06	9.23e-05	CcSEcCtD
Valsartan—Dizziness—Timolol—hypertension	3.72e-06	9.17e-05	CcSEcCtD
Valsartan—Pruritus—Lisinopril—hypertension	3.69e-06	9.1e-05	CcSEcCtD
Valsartan—Vomiting—Ramipril—hypertension	3.66e-06	9.02e-05	CcSEcCtD
Valsartan—Rash—Ramipril—hypertension	3.62e-06	8.94e-05	CcSEcCtD
Valsartan—Dermatitis—Ramipril—hypertension	3.62e-06	8.94e-05	CcSEcCtD
Valsartan—Headache—Ramipril—hypertension	3.6e-06	8.89e-05	CcSEcCtD
Valsartan—Vomiting—Timolol—hypertension	3.57e-06	8.82e-05	CcSEcCtD
Valsartan—Diarrhoea—Lisinopril—hypertension	3.57e-06	8.8e-05	CcSEcCtD
Valsartan—Rash—Timolol—hypertension	3.54e-06	8.74e-05	CcSEcCtD
Valsartan—Dermatitis—Timolol—hypertension	3.54e-06	8.74e-05	CcSEcCtD
Valsartan—Headache—Timolol—hypertension	3.52e-06	8.69e-05	CcSEcCtD
Valsartan—Dizziness—Lisinopril—hypertension	3.45e-06	8.51e-05	CcSEcCtD
Valsartan—Nausea—Ramipril—hypertension	3.41e-06	8.43e-05	CcSEcCtD
Valsartan—Nausea—Timolol—hypertension	3.34e-06	8.24e-05	CcSEcCtD
Valsartan—Vomiting—Lisinopril—hypertension	3.31e-06	8.18e-05	CcSEcCtD
Valsartan—Rash—Lisinopril—hypertension	3.29e-06	8.11e-05	CcSEcCtD
Valsartan—Dermatitis—Lisinopril—hypertension	3.28e-06	8.1e-05	CcSEcCtD
Valsartan—Headache—Lisinopril—hypertension	3.27e-06	8.06e-05	CcSEcCtD
Valsartan—Nausea—Lisinopril—hypertension	3.1e-06	7.64e-05	CcSEcCtD
Valsartan—AGTR1—Signaling Pathways—PRKCB—hypertension	1.25e-06	6.78e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—F2—hypertension	1.25e-06	6.78e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FN1—hypertension	1.25e-06	6.78e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.24e-06	6.77e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—F2—hypertension	1.23e-06	6.7e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PRKCB—hypertension	1.23e-06	6.7e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—FN1—hypertension	1.23e-06	6.7e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—COMT—hypertension	1.23e-06	6.7e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOTCH1—hypertension	1.22e-06	6.64e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS2—hypertension	1.22e-06	6.62e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—hypertension	1.22e-06	6.62e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC2A3—hypertension	1.22e-06	6.61e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALAS1—hypertension	1.22e-06	6.61e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP11B2—hypertension	1.22e-06	6.61e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GNB3—hypertension	1.21e-06	6.61e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPARGC1A—hypertension	1.21e-06	6.61e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—AGT—hypertension	1.21e-06	6.6e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—HMOX1—hypertension	1.21e-06	6.58e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—HSPG2—hypertension	1.2e-06	6.54e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PPARG—hypertension	1.2e-06	6.54e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADA—hypertension	1.2e-06	6.51e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HSD3B1—hypertension	1.2e-06	6.51e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CAT—hypertension	1.19e-06	6.49e-05	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—PPARA—hypertension	1.19e-06	6.48e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOE—hypertension	1.19e-06	6.47e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hypertension	1.19e-06	6.45e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—POMC—hypertension	1.19e-06	6.45e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GNAS—hypertension	1.18e-06	6.43e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—AQP1—hypertension	1.18e-06	6.42e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—FADS1—hypertension	1.18e-06	6.42e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—INS—hypertension	1.18e-06	6.41e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CAV1—hypertension	1.18e-06	6.41e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOA1—hypertension	1.18e-06	6.4e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALOX5—hypertension	1.16e-06	6.32e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GLP1R—hypertension	1.16e-06	6.32e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—hypertension	1.16e-06	6.32e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOB—hypertension	1.16e-06	6.3e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CA9—hypertension	1.15e-06	6.24e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TBXAS1—hypertension	1.15e-06	6.24e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—POMC—hypertension	1.14e-06	6.18e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—hypertension	1.13e-06	6.16e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—INS—hypertension	1.13e-06	6.14e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTM1—hypertension	1.13e-06	6.13e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—hypertension	1.12e-06	6.1e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALOX15—hypertension	1.12e-06	6.08e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALOX5AP—hypertension	1.12e-06	6.08e-05	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—APOA1—hypertension	1.12e-06	6.08e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL2—hypertension	1.11e-06	6.05e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—LPL—hypertension	1.11e-06	6.02e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—hypertension	1.1e-06	6e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF1—hypertension	1.09e-06	5.94e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AKT2—hypertension	1.09e-06	5.94e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HADHA—hypertension	1.09e-06	5.94e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LHB—hypertension	1.09e-06	5.94e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—EGFR—hypertension	1.09e-06	5.91e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADCY5—hypertension	1.08e-06	5.89e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALB—hypertension	1.08e-06	5.88e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IGF1—hypertension	1.08e-06	5.87e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GPX1—hypertension	1.08e-06	5.87e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—AKT2—hypertension	1.08e-06	5.87e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PRKCA—hypertension	1.07e-06	5.81e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP1A1—hypertension	1.07e-06	5.81e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HSD3B2—hypertension	1.07e-06	5.8e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LPA—hypertension	1.07e-06	5.8e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—KCNJ11—hypertension	1.07e-06	5.8e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALDH2—hypertension	1.06e-06	5.78e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CD36—hypertension	1.05e-06	5.72e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SERPINE1—hypertension	1.04e-06	5.64e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PPARG—hypertension	1.04e-06	5.64e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—HBA1—hypertension	1.04e-06	5.63e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NOS3—hypertension	1.03e-06	5.62e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PIK3R1—hypertension	1.03e-06	5.62e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP11A1—hypertension	1.03e-06	5.6e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—hypertension	1.03e-06	5.58e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SERPINE1—hypertension	1.03e-06	5.58e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LRP2—hypertension	1.02e-06	5.56e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2C18—hypertension	1.02e-06	5.56e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—POMC—hypertension	1.02e-06	5.56e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC9A1—hypertension	1.01e-06	5.5e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTT1—hypertension	1.01e-06	5.5e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FGF2—hypertension	1e-06	5.46e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RHOA—hypertension	1e-06	5.44e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GCLC—hypertension	9.99e-07	5.43e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CETP—hypertension	9.99e-07	5.43e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MTHFR—hypertension	9.96e-07	5.42e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—hypertension	9.94e-07	5.4e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PIK3R1—hypertension	9.91e-07	5.39e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOS3—hypertension	9.91e-07	5.39e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—RHOA—hypertension	9.89e-07	5.38e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HSPG2—hypertension	9.85e-07	5.36e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PIK3R1—hypertension	9.79e-07	5.32e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS3—hypertension	9.79e-07	5.32e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPARA—hypertension	9.77e-07	5.31e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—hypertension	9.74e-07	5.3e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—hypertension	9.65e-07	5.25e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—hypertension	9.63e-07	5.23e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP17A1—hypertension	9.57e-07	5.2e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALOX5—hypertension	9.51e-07	5.17e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GLP1R—hypertension	9.51e-07	5.17e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—ENO1—hypertension	9.47e-07	5.15e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS1—hypertension	9.47e-07	5.15e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—AGT—hypertension	9.46e-07	5.15e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS2—hypertension	9.46e-07	5.14e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RELA—hypertension	9.33e-07	5.07e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CALM1—hypertension	9.3e-07	5.06e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOE—hypertension	9.27e-07	5.04e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CAV1—hypertension	9.19e-07	5e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOA1—hypertension	9.17e-07	4.99e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MTOR—hypertension	9.15e-07	4.97e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CTGF—hypertension	9.12e-07	4.96e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GOT2—hypertension	9.04e-07	4.91e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—HMGCR—hypertension	9.04e-07	4.91e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	8.91e-07	4.85e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADRA2A—hypertension	8.84e-07	4.81e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL8—hypertension	8.79e-07	4.78e-05	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—AKT1—hypertension	8.73e-07	4.75e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALDH2—hypertension	8.7e-07	4.73e-05	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—AKT1—hypertension	8.49e-07	4.62e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—hypertension	8.48e-07	4.61e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HBA1—hypertension	8.48e-07	4.61e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP11A1—hypertension	8.42e-07	4.58e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypertension	8.36e-07	4.55e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—hypertension	8.36e-07	4.55e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—TH—hypertension	8.28e-07	4.5e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTT1—hypertension	8.27e-07	4.5e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC9A1—hypertension	8.27e-07	4.5e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CALM2—hypertension	8.25e-07	4.49e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTEN—hypertension	8.25e-07	4.49e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GCLC—hypertension	8.18e-07	4.45e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CETP—hypertension	8.18e-07	4.45e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—hypertension	8.15e-07	4.43e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPARG—hypertension	8.08e-07	4.39e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GCG—hypertension	8.05e-07	4.38e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC2A4—hypertension	8.05e-07	4.38e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—POMC—hypertension	7.97e-07	4.33e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MMP9—hypertension	7.95e-07	4.32e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—INS—hypertension	7.92e-07	4.31e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CDKN1A—hypertension	7.92e-07	4.31e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PTEN—hypertension	7.9e-07	4.3e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—EP300—hypertension	7.86e-07	4.28e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP17A1—hypertension	7.83e-07	4.26e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GOT1—hypertension	7.8e-07	4.24e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS1—hypertension	7.75e-07	4.22e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ENO1—hypertension	7.75e-07	4.22e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAPK8—hypertension	7.73e-07	4.2e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—AKT1—hypertension	7.71e-07	4.19e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hypertension	7.63e-07	4.15e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—STK11—hypertension	7.57e-07	4.12e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP19A1—hypertension	7.57e-07	4.12e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EP300—hypertension	7.54e-07	4.1e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CTGF—hypertension	7.46e-07	4.06e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—EP300—hypertension	7.45e-07	4.05e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GOT2—hypertension	7.4e-07	4.02e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HMGCR—hypertension	7.4e-07	4.02e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SRC—hypertension	7.33e-07	3.99e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	7.29e-07	3.97e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALB—hypertension	7.26e-07	3.95e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SRC—hypertension	7.24e-07	3.94e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADRA2A—hypertension	7.24e-07	3.94e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—VEGFA—hypertension	7.14e-07	3.88e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTEN—hypertension	7.11e-07	3.87e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—VEGFA—hypertension	7.05e-07	3.84e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—COMT—hypertension	7.04e-07	3.83e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PIK3R1—hypertension	6.95e-07	3.78e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NOS3—hypertension	6.95e-07	3.78e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GNB3—hypertension	6.94e-07	3.78e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPARGC1A—hypertension	6.94e-07	3.78e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—HMOX1—hypertension	6.91e-07	3.76e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CAT—hypertension	6.82e-07	3.71e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—EP300—hypertension	6.78e-07	3.69e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TH—hypertension	6.78e-07	3.69e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GNAS—hypertension	6.76e-07	3.68e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CALM2—hypertension	6.75e-07	3.67e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—hypertension	6.67e-07	3.63e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOB—hypertension	6.62e-07	3.6e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GCG—hypertension	6.59e-07	3.59e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC2A4—hypertension	6.59e-07	3.59e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MYC—hypertension	6.57e-07	3.57e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TGFB1—hypertension	6.55e-07	3.56e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TGFB1—hypertension	6.47e-07	3.52e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTM1—hypertension	6.44e-07	3.5e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EGFR—hypertension	6.42e-07	3.49e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GOT1—hypertension	6.38e-07	3.47e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS2—hypertension	6.35e-07	3.46e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—LPL—hypertension	6.32e-07	3.44e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—STK11—hypertension	6.2e-07	3.37e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP19A1—hypertension	6.2e-07	3.37e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADCY5—hypertension	6.19e-07	3.37e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—GPX1—hypertension	6.17e-07	3.35e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PRKCA—hypertension	6.1e-07	3.32e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP1A1—hypertension	6.1e-07	3.32e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CD36—hypertension	6e-07	3.27e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hypertension	5.82e-07	3.16e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—COMT—hypertension	5.76e-07	3.13e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—MTHFR—hypertension	5.69e-07	3.09e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GNB3—hypertension	5.68e-07	3.09e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPARGC1A—hypertension	5.68e-07	3.09e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HMOX1—hypertension	5.66e-07	3.08e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPARA—hypertension	5.58e-07	3.04e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CAT—hypertension	5.58e-07	3.04e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hypertension	5.55e-07	3.02e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTEN—hypertension	5.54e-07	3.01e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GNAS—hypertension	5.53e-07	3.01e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOB—hypertension	5.42e-07	2.95e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—AGT—hypertension	5.41e-07	2.94e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TP53—hypertension	5.39e-07	2.93e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TP53—hypertension	5.33e-07	2.9e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CALM1—hypertension	5.32e-07	2.89e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOE—hypertension	5.3e-07	2.88e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—EP300—hypertension	5.28e-07	2.87e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTM1—hypertension	5.27e-07	2.87e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—CAV1—hypertension	5.25e-07	2.85e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOA1—hypertension	5.24e-07	2.85e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LPL—hypertension	5.17e-07	2.81e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADCY5—hypertension	5.06e-07	2.75e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GPX1—hypertension	5.05e-07	2.74e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PRKCA—hypertension	5e-07	2.72e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP1A1—hypertension	5e-07	2.72e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—hypertension	4.94e-07	2.68e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CD36—hypertension	4.92e-07	2.67e-05	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—AKT1—hypertension	4.75e-07	2.58e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MTHFR—hypertension	4.66e-07	2.53e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPARG—hypertension	4.61e-07	2.51e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPARA—hypertension	4.57e-07	2.49e-05	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AKT1—hypertension	4.55e-07	2.48e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—POMC—hypertension	4.55e-07	2.48e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—INS—hypertension	4.53e-07	2.46e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—AKT1—hypertension	4.5e-07	2.45e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—AGT—hypertension	4.43e-07	2.41e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CALM1—hypertension	4.35e-07	2.37e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOE—hypertension	4.34e-07	2.36e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CAV1—hypertension	4.3e-07	2.34e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOA1—hypertension	4.29e-07	2.33e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PIK3R1—hypertension	3.97e-07	2.16e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—NOS3—hypertension	3.97e-07	2.16e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPARG—hypertension	3.78e-07	2.05e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—POMC—hypertension	3.73e-07	2.03e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—INS—hypertension	3.7e-07	2.01e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS2—hypertension	3.63e-07	1.97e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALB—hypertension	3.4e-07	1.85e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PIK3R1—hypertension	3.25e-07	1.77e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NOS3—hypertension	3.25e-07	1.77e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—AKT1—hypertension	3.19e-07	1.74e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTEN—hypertension	3.17e-07	1.72e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—EP300—hypertension	3.02e-07	1.64e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS2—hypertension	2.97e-07	1.62e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTEN—hypertension	2.59e-07	1.41e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—EP300—hypertension	2.47e-07	1.34e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—AKT1—hypertension	1.82e-07	9.92e-06	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—AKT1—hypertension	1.49e-07	8.12e-06	CbGpPWpGaD
